Sirigen

About:

Sirigen develops light harvesting materials delivering high sensitivity fluorescence for the early detection of life threatening diseases.

Website: http://www.sirigen.com

Top Investors: YFM Equity Partners, Greater Pacific Capital, Oxford Capital, IQ Capital, Nesta Ventures

Description:

Harnessing the power of novel light-harvesting polymeric materials, Sirigen’s amplification technology offers High Sensitivity Fluorescence™ (HSF™) detection to the Diagnostic and Life Science marketplaces. Sirigen’s versatile and HSF™ technology simplifies sample processing and instrumentation requirements in both immunodiagnostic and nucleic acid based applications, and facilitates high volume screening in theradiagnostics and other personal care applications.

Total Funding Amount:

$18.9M

Headquarters Location:

Ringwood, Hampshire, United Kingdom

Founded Date:

2003-01-01

Contact Email:

info(AT)sirigen.com

Founders:

Brent S. Gaylord, Guillermo C. Bazan, Patrick Dietzen

Number of Employees:

11-50

Last Funding Date:

2012-02-17

IPO Status:

Private

Industries:

© 2025 bioDAO.ai